Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up

Research output: Contribution to journalArticlepeer-review

  • External authors:
  • Roger Hagen
  • Odin Hjemdal
  • Stian Solem
  • Leif Kennair
  • Hans M. Nordahl
  • Peter Fisher


This randomized controlled trial examines the efficacy of metacognitive therapy (MCT) for depression. Thirty-nine patients with depression were randomly assigned to immediate
MCT (10 sessions) or a 10-week wait list period (WL). The WL-group received 10 sessions of MCT after the waiting period. Two participants dropped out from WL and none dropped out of immediate MCT treatment. Participants receiving MCT improved
significantly more than the WL group. Large controlled effect sizes were observed for both depressive (d = 2.51) and anxious symptoms (d = 1.92). Approximately 70–80% could be classified as recovered at post-treatment and 6 months follow-up following immediate MCT, whilst 5% of the WL patients recovered during the waiting period. The results suggest that MCT is a promising treatment for depression. Future controlled
studies should compare MCT with other active treatments.

Bibliographical metadata

Original languageEnglish
Pages (from-to)1-10
Number of pages11
JournalFrontiers in Psychology
Publication statusPublished - 24 Jan 2017

Related information


View all